Drug
Rmc 9805
Rmc 9805: highest development phase Phase 1, developed by Revolution Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Revolution Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| RMC-9805 NCT06040541 | Phase 1 | Non-small Cell Lung Cancer (NSCLC) |
Latest
No recent events.
Follow Rmc 9805 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.